Stay updated on ARO-HIF2 in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the ARO-HIF2 in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the ARO-HIF2 in Renal Cell Carcinoma Clinical Trial page
- Check3 days agoChange DetectedThe page revision updated the version from v3.5.3 to v3.5.4, indicating a small update to the ClinicalTrials.gov entry, with no change to the listed study details or eligibility criteria.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site update rather than a change to the underlying study details.SummaryDifference0.1%

- Check32 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 across the site. No visible content changes were detected.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check96 days agoChange DetectedRevision: v3.4.2 was added to the page, indicating a minor update. The prior funding-status notice and the previous revision tag 'Revision: v3.4.1' were removed.SummaryDifference0.5%

Stay in the know with updates to ARO-HIF2 in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-HIF2 in Renal Cell Carcinoma Clinical Trial page.